Heart failure & cardiomyopathiesMeta-analysis
Telemonitoring for heart failure: a meta-analysis
- Systematic review and meta-analysis of randomised trials and observational studies
- random-effects
Authors' conclusion
These results are an advocacy for the use of hTMS in HF patients to reduce all-cause mortality and HF-related hospitalizations.
Study context
- Population
- Patients with heart failure (HF); studies published January 1996–July 202265 non-invasive + 27 invasive home telemonitoring systems (hTMS) studies
- Participants
- 36,549 patients
- Comparison
- Home telemonitoring vs standard of care
- Outcome
- All-cause mortality, first HF hospitalization and total HF hospitalizations
- Follow-up
- Mean 11.5 months
Pooled result
As reported in the abstract
hTMS vs Standard of careEstimate (95% CI)
all-cause mortality; I2: 24%
OR 0.84(0.77–0.93)
first HF hospitalization; I2: 22%
OR 0.81(0.74–0.88)
total HF hospitalizations; I2: 70%
IRR 0.85(0.76–0.96)
Original publication
Telemonitoring for heart failure: a meta-analysis. Eur Heart J. Published 22 May 2023. doi:10.1093/eurheartj/ehad280
Summarised from the published abstract; every number is checked against it